Clinical Trials Logo
  1. Home
  2. Primary Sjögren Syndrome
  3. NCT04830644

A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.

Primary Sjögren Syndrome Clinical Trial

Official title:
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study to Evaluate the Efficacy and Safety of Iguratimod in Patients With Active Primary Sjogren's Syndrome.

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of iguratimod compared to placebo in patients with active primary Sjogren's Syndrome.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04830644
Study type Interventional
Source Jiangsu Simcere Pharmaceutical Co., Ltd.
Contact Lai Zhiqiang
Phone +86-18697190725
Email laizhiqiang@simcere.com
Status Recruiting
Phase Phase 2
Start date March 22, 2021
Completion date June 2022
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06440525 - A Phase 2 Study of RSLV-132 in Females With Primary Sjögren's Syndrome Phase 2
Not yet recruiting NCT03140111 - LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients N/A
Not yet recruiting NCT06049368 - 68Ga-P16-093 PET/CT Imaging in the Salivary Gland Phase 1/Phase 2
Not yet recruiting NCT03614299 - Eye Dryness Evaluation in Primary Sjögren's Syndrome
Not yet recruiting NCT03126383 - Inflammatory Myopathies in Primary Sjögren's Syndrome N/A
Not yet recruiting NCT03765593 - Biomarkers in Primary Sjögren's Syndrome
Completed NCT01081184 - Neurotrophins Implications in Primary Sjögren Syndrome N/A
Completed NCT05670535 - Sjögren and Gynecologic Considerations
Completed NCT03226444 - Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome Phase 1/Phase 2
Completed NCT04816370 - Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions N/A
Completed NCT05380804 - Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
Terminated NCT04700280 - A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) Phase 2
Completed NCT03130062 - Resistance Exercise in Woman With Primary Sjörgen Syndrome. N/A
Completed NCT04093531 - Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome Phase 1
Recruiting NCT03509064 - Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
Completed NCT04224454 - Vaccine Coverage and Primary Sjögren'Syndrome
Completed NCT04960605 - Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome N/A
Recruiting NCT06361745 - Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases N/A